会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • 2(1H)-quinolone compounds
    • 2(1H) - 喹诺酮化合物
    • US5646132A
    • 1997-07-08
    • US499946
    • 1995-07-10
    • Alex CordiPatrice DesosJean Lepagnol
    • Alex CordiPatrice DesosJean Lepagnol
    • A61K31/675A61P25/00A61P25/08A61P25/18A61P25/28A61P43/00C07F9/576C07F9/60
    • C07F9/5765C07F9/60
    • Compound of formula (I): ##STR1## in which: R.sub.1, R.sub.2 and R.sub.3, which are identical or different, represent hydrogen or halogen or alkyl, nitro, cyano or aminosulfonyl, or alternatively, when two of them are located on adjacent carbons, form, with the carbon atoms to which they are attached, (C.sub.3 -C.sub.7) cycloalkyl ring or substituted or unsubstituted benzene ring,R.sub.4 represents hydrogen, linear or branched (C.sub.1 -C.sub.6) alkyl, substituted or unsubstituted phenyl or a group ##STR2## in which R.sub.6 and R.sub.7, which are identical or different, represent hydrogen or substituted or unsubstituted, linear or branched (C.sub.1 -C.sub.6) alkyl,R.sub.5 represents hydrogen, hydroxyl, linear or branched (C.sub.1 -C.sub.6) alkoxy, phenoxy, mercapto, linear or branched (C.sub.1 -C.sub.6) alkylthio, substituted or unsubstituted, linear or branched (C.sub.1 -C.sub.6) alkyl, substituted or unsubstituted phenyl or substituted or unsubstituted amino, or a group ##STR3## in which R.sub.6 and R.sub.7 are as defined above, their isomers as well as their addition salts with a pharmaceutically acceptable acid or base, and medicinal product containing the same are useful as inhibitor of the pathological phenomena associated with hyperactivation of the excitating amino acid-dependant pathways of neurotransmission.
    • 式(I)化合物:其中:R 1,R 2和R 3相同或不同,表示氢或卤素或烷基,硝基,氰基或氨基磺酰基,或者当其中两个位于 (C 3 -C 7)环烷基环或取代或未取代的苯环,R 4表示氢,直链或支链(C 1 -C 6)烷基,取代或未取代的苯基或取代或未取代的苯基 基团其中R6和R7相同或不同,表示氢或取代或未取代的直链或支链(C1-C6)烷基,R5表示氢,羟基,直链或支链(C1-C6)烷氧基,苯氧基 (C1-C6)烷基,取代或未取代的直链或支链(C1-C6)烷基,取代或未取代的苯基或取代或未取代的氨基,或其中R6和R7为 它们的异构体以及它们与药物的加成盐 可接受的酸或碱,以及含有它们的药物可用作与神经传递的兴奋性氨基酸依赖性途径的高活化相关的病理现象的抑制剂。
    • 7. 发明授权
    • Benzothiazine and benzothiadiazine compounds
    • 苯并噻嗪和苯并噻二嗪化合物
    • US07250411B2
    • 2007-07-31
    • US10499082
    • 2002-12-20
    • Alex CordiPatrice DesosPierre Lestage
    • Alex CordiPatrice DesosPierre Lestage
    • C07D285/22A61K31/5415A61P25/24
    • C07D285/24C07D279/02
    • Compounds of formula (I): wherein: R1 represents hydroxy or RCO—O—, R2 represents hydrogen, halogen, hydroxy or R′CO—O, R, R′, which may be identical or different, represent linear or branched (C1-C6)alkyl optionally substituted by aryl, linear or branched (C2-C6)alkenyl optionally substituted by aryl, linear or branched (C1-C6)perhaloalkyl, (C3-C7)cycloalkyl, adamantyl, aryl or heteroaryl, R3 represents hydrogen, linear or branched (C1-C6)alkyl or (C3-C7)cycloalkyl, A represents CR4R5 or NR4, R4 represents hydrogen or linear or branched (C1-C6)alkyl,their isomers and also their addition salts with a pharmaceutically acceptable acid or base.Medicaments.
    • 式(I)化合物:其中:R 1表示羟基或RCO-O-,R 2表示氢,卤素,羟基或R'CO-O,R, R'可以相同或不同,表示直链或支链(C 1 -C 6 -C 6)烷基,其任选被直链或支链的芳基(C 2 任选被芳基,直链或支链(C 1 -C 6 -C 6)全卤代烷基取代的(C 1 -C 6 - 金刚烷基,芳基或杂芳基,R 3表示直链或支链(C 1 -C 3)烷基的氢, C 1 -C 6烷基或(C 3 -C 7 -C 7)环烷基,A表示CR 4 R 7, R 5或NR 4,R 4表示氢或直链或支链(C 1 -C 6 - /它们的异构体,以及它们与药学上可接受的酸或碱的加成盐。 药剂
    • 9. 发明授权
    • 2(1H)-quinolone compounds
    • 2(1H) - 喹诺酮化合物
    • US5536709A
    • 1996-07-16
    • US297793
    • 1994-08-30
    • Alex CordiPatrice DesosJean Lepagnol
    • Alex CordiPatrice DesosJean Lepagnol
    • A61K31/675A61P25/00A61P25/08A61P25/18A61P25/28A61P43/00C07F9/576C07F9/60C07D215/227C07F9/38
    • C07F9/5765C07F9/60
    • Compound of formula (I): ##STR1## in which R.sub.1, R.sub.2 and R.sub.3, which are identical or different, represent hydrogen or halogen or alkyl, nitro, cyano or aminosulfonyl, or alternatively, when two of them are located on adjacent carbons, form, with the carbon atoms to which they are attached, (C.sub.3 -C.sub.7) cycloalkyl ring or substituted or unsubstituted benzene ring,R.sub.4 represents hydrogen, linear or branched (C.sub.1 -C.sub.6) alkyl, substituted or unsubstituted phenyl or a group ##STR2## in which R.sub.6 and R.sub.7, which are identical or different, represent hydrogen or substituted or unsubstituted, linear or branched (C.sub.1 -C.sub.6) alkyl,R.sub.5 represents hydrogen, hydroxyl, linear or branched (C.sub.1 -C.sub.6) alkoxy, phenoxy, mercapto, linear or branched (C.sub.1 -C.sub.6) alkylthio, substituted or unsubstituted, linear or branched (C.sub.1 -.sub.6) alkyl, substituted or unsubstituted phenyl or substituted or unsubstituted amino; or a group ##STR3## in which R.sub.6 and R.sub.7 are as defined above, their isomers as well as their addition salts with a pharmaceutically acceptable acid or base, and medicinal product containing the same are useful as inhibitor of the pathological phenomena associated with hyperactivation of the excitating amino acid-dependant pathways of neurotransmission.
    • 式(I)化合物:其中R 1,R 2和R 3相同或不同,表示氢或卤素或烷基,硝基,氰基或氨基磺酰基,或者当它们中的两个位于 (C 3 -C 7)环烷基环或取代或未取代的苯环,R 4表示氢,直链或支链(C 1 -C 6)烷基,取代或未取代的苯基或基团 其中R6和R7相同或不同,表示氢或取代或未取代的直链或支链(C1-C6)烷基,R5代表氢,羟基,直链或支链(C1-C6)烷氧基,苯氧基, 直链或支链(C1-C6)烷硫基,取代或未取代的直链或支链(C1-6)烷基,取代或未取代的苯基或取代或未取代的氨基; 或其中R 6和R 7如上所定义的基团,其异构体及其与药学上可接受的酸或碱的加成盐,以及含有它们的药物可用作与超活化相关的病理现象的抑制剂 兴奋性氨基酸依赖的神经传递途径。